Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

160
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
160

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Microparticles synthesized from itaconate polyesters enable metabolite delivery and elicit immunoregulatory outcomes.

Journal of controlled release : official journal of the Controlled Release Society·2026
Same author

Integrating molecular dynamics simulations to enable rational assembly of immune signals for immunotherapy.

Nanoscale horizons·2026
Same author

PEGylation strategies for enhanced nanoparticle delivery to tumor-associated immune cells.

Bioengineering & translational medicine·2026
Same author

Triple-junction solar cells with improved carrier and photon management.

Nature·2026
Same author

Optimizing genetic engineering approaches for protein loading into bacterial extracellular vesicles for vaginal drug delivery.

Journal of controlled release : official journal of the Controlled Release Society·2026
Same author

BCMA-directed mRNA CAR T cell therapy for myasthenia gravis: a randomized, double-blind, placebo-controlled phase 2b trial.

Nature medicine·2026

Related Experiment Video

Updated: May 4, 2026

Intra-lymph Node Injection of Biodegradable Polymer Particles
09:06

Intra-lymph Node Injection of Biodegradable Polymer Particles

Published on: January 2, 2014

17.0K

Intra-lymph node injection of biodegradable polymer particles.

James I Andorko1, Lisa H Tostanoski, Eduardo Solano

  • 1Fischell Department of Bioengineering, University of Maryland, College Park.

Journal of Visualized Experiments : Jove
|January 17, 2014
PubMed
Summary

Directly injecting biodegradable polymer particles into lymph nodes enhances adaptive immune responses. This novel biomaterial vaccine strategy allows precise control over antigen and adjuvant delivery for improved vaccine development.

More Related Videos

Intralymphatic Immunotherapy and Vaccination in Mice
07:33

Intralymphatic Immunotherapy and Vaccination in Mice

Published on: February 2, 2014

22.5K
Immunostimulatory Agent Evaluation: Lymphoid Tissue Extraction and Injection Route-Dependent Dendritic Cell Activation
07:04

Immunostimulatory Agent Evaluation: Lymphoid Tissue Extraction and Injection Route-Dependent Dendritic Cell Activation

Published on: September 16, 2018

9.2K

Related Experiment Videos

Last Updated: May 4, 2026

Intra-lymph Node Injection of Biodegradable Polymer Particles
09:06

Intra-lymph Node Injection of Biodegradable Polymer Particles

Published on: January 2, 2014

17.0K
Intralymphatic Immunotherapy and Vaccination in Mice
07:33

Intralymphatic Immunotherapy and Vaccination in Mice

Published on: February 2, 2014

22.5K
Immunostimulatory Agent Evaluation: Lymphoid Tissue Extraction and Injection Route-Dependent Dendritic Cell Activation
07:04

Immunostimulatory Agent Evaluation: Lymphoid Tissue Extraction and Injection Route-Dependent Dendritic Cell Activation

Published on: September 16, 2018

9.2K

Area of Science:

  • Immunology
  • Biomaterials Science
  • Vaccine Development

Background:

  • Adaptive immune responses depend on antigen transport to lymph nodes for T and B lymphocyte activation.
  • Lymph nodes are key targets for advanced vaccines and immunotherapies.
  • Direct lymph node injection and biomaterial particle size tuning are emerging strategies for improved targeting.

Purpose of the Study:

  • To present a novel method combining direct lymph node injection with biodegradable polymer particles for vaccine delivery.
  • To demonstrate precise control over the dosage and combination of vaccine components delivered to lymph nodes.

Main Methods:

  • Biodegradable polymeric microparticles and nanoparticles were synthesized using a modified double emulsion protocol with lipid stabilizers.
  • Particle size and cargo loading were characterized using laser diffraction and fluorescent microscopy.
  • Mouse lymph nodes were targeted via peripheral injection of a tracer dye, followed by deposition of polymer particles.

Main Results:

  • The developed method successfully enabled direct lymph node injection of biodegradable polymer particles.
  • Particle properties, including size and antigen/adjuvant loading, were confirmed.
  • The technique allowed for precise delivery and control of vaccine components to the target lymph nodes.

Conclusions:

  • This combined approach of direct lymph node injection and biodegradable polymer particles offers a promising strategy for new vaccine development.
  • The method provides enhanced control over biomaterial and vaccine component delivery to lymph nodes.
  • This technique could be instrumental in advancing the field of biomaterial-based vaccines.